Mandate

Gleiss Lutz advises Apax Partners on the acquisition of Azelis

Gleiss Lutz has advised funds of London based private equity investors Apax Partners on the acquisition of the Azelis Group. The speciality chemicals distributor with registered office in Antwerp, Belgium, was hitherto owned by investors 3i Group Plc.  

Azelis achieves a worldwide turnover of 1 billion Euro and employs around 1100 staff in 34 countries, including in Europe, China, Australia, Canada, India, Japan and Malaysia. In Germany, Azelis is represented at locations in Krefeld, Moers and Sankt Augustin, where it is particularly active in the pharma, personal care and food ingredient industries along with the distribution of chemicals.  

Apax Partners has operated as an investor for more than 30 years, advising funds worldwide with a total volume in excess of 40 billion US dollars. It specialises in the sectors of Consumer, Healthcare, Services and Tech & Telco.  

Apax Partners was advised by the following Gleiss Lutz team: Dr. Jan Bauer (Partner), Dr. Rüdiger Schmidt-Bendun (both lead, Corporate/M&A), Dr. Doris-Maria Schuster (Partner, Employment), Dr. Tim Weber (Partner, Real Estate), Dr. Hendrik Plath (Corporate/M&A, all Frankfurt), Dr. Jan Stenger (Corporate/M&A, Stuttgart), Christian Mathias (Employment), Dr. Linda Schlegel (Real Estate) and Frank Schlobach (Banking and Finance, all Frankfurt).  

Simpson Thatcher Bartlett LLP (Derek Baird and Ian Barratt) advised on English law.  

Forward